How to buy Probiotec shares
Own Probiotec shares in just a few minutes.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Probiotec Limited is a drug manufacturers-specialty & generic business based in Australia. Probiotec shares (PBP) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Probiotec has a trailing 12-month revenue of around $105.7 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Probiotec
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Probiotec . Find the share by name or ticker symbol: PBP. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Probiotec reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Probiotec . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Probiotec share priceUse our graph to track the performance of PBP stocks over time.
Probiotec shares at a glance
|52-week range||$1.6227 - $2.4777|
|50-day moving average||$2.0258|
|200-day moving average||$2.2026|
|Dividend yield||$0.05 (2.29%)|
|Earnings per share (TTM)||$0.054|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Probiotec stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Probiotec price performance over time
|1 week (2021-06-07)||-1.51%|
|1 month (2021-05-14)||-2.97%|
|3 months (2021-03-12)||-12.50%|
|6 months (2020-12-14)||-20.33%|
|1 year (2020-06-12)||12.97%|
|2 years (2019-06-14)||25.64%|
|3 years (2018-06-14)||64.02%|
|5 years (2016-06-14)||273.33%|
Is Probiotec under- or over-valued?
Valuing Probiotec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Probiotec 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Probiotec 's P/E ratio
Probiotec 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 41x. In other words, Probiotec shares trade at around 41x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Probiotec 's EBITDA
Probiotec 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14 million.
The EBITDA is a measure of a Probiotec 's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$105.7 million|
|Operating margin TTM||9.91%|
|Gross profit TTM||$31.8 million|
|Return on assets TTM||4.33%|
|Return on equity TTM||9.38%|
|Market capitalisation||$174.2 million|
TTM: trailing 12 months
Probiotec share dividends
Dividend payout ratio: 62.5% of net profits
Recently Probiotec has paid out, on average, around 62.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.05% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Probiotec shareholders could enjoy a 2.05% return on their shares, in the form of dividend payments. In Probiotec 's case, that would currently equate to about A$0.05 per share.
Probiotec 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 2 March 2021 (the "ex-dividend date").
Probiotec share price volatility
Over the last 12 months, Probiotec 's shares have ranged in value from as little as $1.6227 up to $2.4777. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Probiotec 's is 0.4439. This would suggest that Probiotec 's shares are less volatile than average (for this exchange).
Probiotec Limited engages in the development, manufacture and sale of pharmaceuticals, consumer health, and nutraceutical products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, and ointments and suspensions; powders and powder blending; and sprays, as well as manufacturing and packaging of finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services and formats, including foil, carded and clamshell blister packing, bottle filling, labelling, secondary packaging, and other services for the pharmaceutical, cosmetic, and food industries. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.
Frequently asked questions
More guides on Finder
How to buy Probiotec shares
Steps to owning and managing Regency Centers shares.
How to buy The Honest Company (HNST) shares from Australia
Here's everything we know so far about The Honest Company IPO and how to buy in from Australia.
How to buy Probiotec shares
Steps to owning and managing Applyflow shares.
Cheap gas providers in SA
Compare gas plans from South Australia providers. Find a better deal and switch today.
Best headphones in Australia
Our expert team of reviewers pick the best headphones in Australia, with a little help from real consumer reviews.
Best fountain pens in Australia
From the best fountain pen for beginners to the top high-end model, these are the seven best fountain pens you can buy in Australia right now.
How to buy Marqeta stock from Australia when it goes public
Here's everything we know so far about the Marqeta IPO and how to buy in from Australia.
Best shower heads in Australia
We read hundreds of customer reviews to find the best shower heads you can buy online and in-store in Australia.
How to invest in the Didi Chuxing IPO from Australia
Everything we know about the Didi Chuxing IPO, plus information on how to buy in.
How to buy Robinhood stock from Australia
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
Ask an Expert